NASDAQ: LFSTLifestance Health Group Inc Stock
$5.71+0.02 (+0.35%)
Updated Apr 18, 2024
LFST Price
$5.71
Fair Value Price
N/A
Market Cap
$2.17B
52 Week Low
$4.74
52 Week High
$9.59
P/E
-11.2x
P/B
1.52x
P/S
2.73x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.06B
Earnings
-$186.26M
Gross Margin
28.6%
Operating Margin
-17.56%
Profit Margin
-17.6%
Debt to Equity
0.48
Operating Cash Flow
-$17M
Beta
1.71
Next Earnings
Apr 29, 2024
Ex-Dividend
N/A
Next Dividend
N/A
LFST Overview
LifeStance Health Group Incorporated offers psychiatric evaluations and treatment, psychological and neuropsychological testing, as well as individual, family, and group therapy. The company treats anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. It provides care online and in person at centers in 32 states. LifeStance was founded in 2017 and is based in Scottsdale, AZ.
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how LFST scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
LFST is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
LFST is good value based on its book value relative to its share price (1.52x), compared to the US Medical Care Facilities industry average (4.36x)
P/B vs Industry Valuation
LFST is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more LFST due diligence checks available for Premium users.
Be the first to know about important LFST news, forecast changes, insider trades & much more!
LFST News
Valuation
LFST fair value
Fair Value of LFST stock based on Discounted Cash Flow (DCF)
Price
$5.71
Fair Value
$6.85
Undervalued by
16.63%
LFST is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
LFST price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-11.2x
Industry
-3.03x
Market
41.33x
LFST price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.52x
Industry
4.36x
LFST is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
LFST's financial health
Profit margin
Revenue
$280.6M
Net Income
-$45.0M
Profit Margin
-16%
LFST's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
LFST's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.1B
Liabilities
$681.0M
Debt to equity
0.48
LFST's short-term assets ($225.73M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LFST's long-term liabilities ($478.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LFST's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$16.8M
Investing
-$11.4M
Financing
$30.8M
LFST's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
LFST vs Medical Care Facility Stocks
Lifestance Health Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.